Biogen Inc.
BIIB
$199.36
$1.410.71%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.28B | 3.82B | 3.96B | 2.76B | 2.60B |
| Total Receivables | 1.79B | 1.87B | 1.85B | 2.08B | 2.00B |
| Inventory | 1.95B | 2.17B | 2.21B | 2.27B | 2.27B |
| Prepaid Expenses | 661.60M | 693.60M | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 506.70M | 429.70M | 916.80M | 850.60M | 757.30M |
| Total Current Assets | 9.19B | 8.97B | 8.94B | 7.97B | 7.63B |
|
|
|||||
| Total Current Assets | 9.19B | 8.97B | 8.94B | 7.97B | 7.63B |
| Net Property, Plant & Equipment | 3.27B | 3.32B | 3.41B | 3.43B | 3.48B |
| Long-term Investments | 6.49B | 6.49B | 6.49B | 6.49B | 6.48B |
| Goodwill | 6.49B | 6.49B | 6.49B | 6.49B | 6.48B |
| Total Other Intangibles | 9.05B | 9.18B | 9.33B | 9.47B | 9.58B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 470.40M | 520.50M | 556.50M | 561.60M | 472.70M |
| Total Assets | 29.48B | 29.44B | 29.21B | 28.33B | 28.03B |
|
|
|||||
| Total Accounts Payable | 358.50M | 432.00M | 413.10M | 408.40M | 391.50M |
| Total Accrued Expenses | 1.46B | 1.68B | 1.69B | 1.46B | 1.32B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 80.40M | -- | -- | 1.75B |
| Total Finance Division Other Current Liabilities | 1.18B | 1.16B | 1.18B | 1.32B | 1.83B |
| Total Other Current Liabilities | 1.18B | 1.16B | 1.18B | 1.32B | 1.83B |
| Total Current Liabilities | 3.00B | 3.35B | 3.29B | 3.18B | 5.30B |
|
|
|||||
| Total Current Liabilities | 3.00B | 3.35B | 3.29B | 3.18B | 5.30B |
| Long-Term Debt | 6.29B | 6.29B | 6.29B | 6.28B | 4.55B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 273.40M | 290.40M | 305.00M | 310.90M | 323.40M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.27B | 1.26B | 1.12B | 917.90M | 884.90M |
| Total Liabilities | 10.83B | 11.18B | 11.00B | 10.70B | 11.05B |
|
|
|||||
| Common Stock & APIC | 896.80M | 863.20M | 797.80M | 714.10M | 630.00M |
| Retained Earnings | 20.87B | 20.55B | 20.60B | 20.14B | 19.50B |
| Treasury Stock & Other | -3.12B | -3.16B | -3.19B | -3.22B | -3.15B |
| Total Common Equity | 18.65B | 18.26B | 18.21B | 17.63B | 16.98B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 18.65B | 18.26B | 18.21B | 17.63B | 16.98B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 18.65B | 18.26B | 18.21B | 17.63B | 16.98B |
|
|
|||||